Boston Scientific Bemoans ICD Market Slide, Cements Cardiovascular Focus
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific may have to adjust revenue projections for its newly acquired Guidant unit due to slowdowns in the cardiac rhythm management market